Lessons from the Vulvar Dermatology Clinic: Diagnosis & Management Pearls
Vulvar dermatology is one of those areas where small misses can really add up. Symptoms can affect quality of life, and in some cases, result in scarring and permanent architecture changes. Dr Murphy—assistant professor of Dermatology and director of the Vulvar Health Program at George Washington University—walked through six key lessons she’s learned from caring for patients with vulvar dis …
Vulvar dermatology is one of those areas where small misses can really add up. Symptoms can affect quality of life, and in some cases, result in scarring and permanent architecture changes. Dr Murphy—assistant professor of Dermatology and director of the Vulvar Health Program at George Washington University—walked through six key lessons she’s learned from caring for patients with vulvar dis … Continue reading "Lessons from the Vulvar Dermatology Clinic: Diagnosis & Management Pearls"
Dermatologists treat more than 3,000 conditions, but not all of them receive equal attention. In this Next Steps in Derm video interview, in partnership with the ODAC Dermatology Conference, ODAC Conference Co-Chair Adam Friedman, MD, FAAD, addresses common, yet overlooked skin conditions, most of which do not have FDA-approved therapies. Watch and learn tips for the creative management of lichen … 
A 40-year-old female develops a wing of extra tissue in all of her fingernails which developed gradually through the years. You mention it is due to scarring in the nail matrix. What is the most common dermatologic association with this condition?
A. Lichen planus
B. Trauma
C. Stevens-Johnson syndrome
D. Alopecia areata
E. Renal failure
To find out the correct answer and read t … 
Histopathology can be rendered useless without good clinical information, according to Dr. Olayemi Sokumbi, a dermatologist and dermatopathologist with Mayo Clinic. Next Steps in Derm, in partnership with ODAC Dermatology, Aesthetic & Surgical Conference, interviewed Dr. Sokumbi about traps to avoid in challenging clinicopathologic scenarios. Learn how not to miss a diagnosis of dermatomyosit … 
Bimekizumab (Bimzelx®) is a new injectable medication FDA approved for plaque psoriasis. It is the first and only FDA approved IL-17A and IL-17F inhibitor for this disease, but is also being used as an off-label option for other conditions including psoriatic arthritis and hidradenitis suppurativa. This Therapeutic Cheat Sheet will focus on the on and off label uses of bimekizumab.
Bimekizuma …